about
Characterization of a high-affinity sialic acid-specific CBM40 from Clostridium perfringens and engineering of a divalent formSynthesis of ether oligomers.Neoglycopeptide dendrimer libraries as a source of lectin binding ligands.Randomized combinatorial library of heteroglycoclusters (hGC).Phenolic oxime oligomers inhibit Alzheimer's amyloid fibril formation and disaggregate fibrils in vitro.Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunityMultivalent glycoconjugates as anti-pathogenic agentsSynthesis of heteroglycoclusters by using orthogonal chemoselective ligationsA cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.Application of click-click chemistry to the synthesis of new multivalent RGD conjugates.Multivalent glyco(cyclo)peptides.Oxime ligation: a chemoselective click-type reaction for accessing multifunctional biomolecular constructs.Multivalent glycocyclopeptides: toward nano-sized glycostructures.Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.Electrochemical detection of Arachis hypogaea (peanut) agglutinin binding to monovalent and clustered lactosyl motifs immobilized on a polypyrrole film.Preparation of a multitopic glycopeptide-oligonucleotide conjugate.Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.Aminooxylated Carbohydrates: Synthesis and Applications.Synthesis of multivalent glycoconjugates containing the immunoactive LELTE peptide: effect of glycosylation on cellular activation and natural killing by human peripheral blood mononuclear cells.Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes.Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.Role of a Preorganized Scaffold Presenting Four Residues of a GM-3 Lactone Mimetic on Melanoma Progression.Synthesis of a New Series of Sialylated Homo- and Heterovalent Glycoclusters by using Orthogonal Ligations.Re-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides.Orthogonal dual thiol-chloroacetyl and thiol-ene couplings for the sequential one-pot assembly of heteroglycoclustersRecent progress in antitumoral synthetic vaccines.Methyl 2,3,6-tri-O-benzoyl-4-deoxy-4-methoxyamino-alpha-D-glucopyranoside.Surface patterning of (bio)molecules onto the inner wall of fused-silica capillary tubes.N-(2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-alpha-D-galactopyranosyloxy)succinimide.Tetravalent glycocyclopeptide with nanomolar affinity to wheat germ agglutinin.Multivalent scaffolds in glycoscience: an overview.Highly efficient synthesis of peptide- and carbohydrate-oligonucleotide conjugates using chemoselective oxime and thiazolidine formation.The oxime bond formation as an efficient chemical tool for the preparation of 3',5'-bifunctionalised oligodeoxyribonucleotides.Aldehyde detection by chromogenic/fluorogenic oxime bond fragmentation.A cyclodecapeptide ligand to vitamin B12.Promotion of sugar-lectin recognition through the multiple sugar presentation offered by regioselectively addressable functionalized templates (RAFT): a QCM-D and SPR study.Chemoselectively addressable template: a valuable tool for the engineering of molecular conjugates.Multivalent Glycomimetics with Affinity and Selectivity toward Fucose-Binding Receptors from Emerging Pathogens.
P50
Q27704909-2A7F6BC2-2F40-44EC-BC08-BEA9B05E9FA7Q33197171-5DAFFDE7-CF42-43A3-8238-CF48D315292BQ33277901-54D1FE29-67B5-45EE-9923-61CB3350C9BAQ33327910-45E1C08C-8F92-4E55-9631-F8A29B176533Q33439036-8A249A88-9633-4A03-A1F5-13C2CFE9CB53Q33614657-57BE4E60-95ED-426B-9C2C-8926CC3000C7Q33614657-C27E2F39-91D3-444D-A943-92365EEBFFD7Q35444698-72876981-B9AA-4C40-B019-2462EE8A92F0Q35889794-84E58C44-DF9F-400B-97E4-0DF33A6CA5E2Q36042286-7C1B7BC4-94CE-4A6D-8AEF-2D1CDDF97B8EQ36773033-E5FF2D82-E1F6-4F8B-9D0E-5E5F257B0AD9Q38069441-B5C90FA9-9F94-45A1-B5F8-3F9B7C9279E1Q38168504-81D9AC53-9A9F-4BD0-9419-56FBC2BA1B01Q38286652-942EA689-3140-4C36-8306-D642E83195F9Q38299025-A94141A3-DF55-4113-9F3C-3E5C0FDB730BQ38321891-38B9A4BF-8DA6-4EE5-9C23-EA6C9D387448Q38328939-E29E5B98-D398-4EFF-9984-3A711E64F90EQ38337529-678867C1-7C66-4AA5-946E-473CF4F63F4DQ38802224-9419EEB6-BBBE-4667-AFD7-76DC009385DEQ39169715-F0D47C9B-9C78-4966-A083-95DA358771DAQ39417928-163A4190-082C-455D-8A2D-A75382161C7DQ39879576-D2F47109-FB93-4EC4-B68E-35A751DBE03FQ39967691-AEC23696-D352-497D-914D-6B80CBA11885Q40023040-B4CFD0E3-7961-49CA-93B8-171D413E7789Q40050341-C7A8772B-78AC-45C6-B46C-FA0756C6F7AAQ41446300-923B8842-4D78-403A-8560-B086AF92010DQ41902082-DC170D09-4A6B-477D-AA1E-E442863A8E14Q42837589-71311BCB-DB84-4181-8F78-6F95877077C5Q43007810-D4C7D5DB-8469-4A5E-A5BE-69DEF0F51E28Q43543343-F5D2CCB1-C4F0-45C4-8E1A-117D454F8857Q43593774-0A09A35A-1FF2-4BE6-A084-63C2FFB8885AQ43608074-B391E040-2B62-4FA9-8653-146AFFB1FF6DQ43786612-05FAAB74-DA22-4F93-8518-A2BE7A91D8B2Q44038908-4FB4781E-82C3-4343-8D40-9336B3814B2DQ44622244-E0F081A2-CE5A-4CAA-B3DC-DE6F2D28E8E1Q44882654-B4845DDC-12D5-49BF-A111-18E7F45AF226Q44891319-F63B2ED9-E999-4966-8F20-14C6D77C344CQ46275056-142247E7-AE5F-446D-84E6-0B49CE31D896Q46713304-F1827CCA-DD56-4FC8-B68E-92B227AAA306Q46982755-2AF55487-D1A5-493A-9C68-E5FC99F56409
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Olivier Renaudet
@ast
Olivier Renaudet
@en
Olivier Renaudet
@es
Olivier Renaudet
@fr
Olivier Renaudet
@nl
Olivier Renaudet
@sl
type
label
Olivier Renaudet
@ast
Olivier Renaudet
@en
Olivier Renaudet
@es
Olivier Renaudet
@fr
Olivier Renaudet
@nl
Olivier Renaudet
@sl
prefLabel
Olivier Renaudet
@ast
Olivier Renaudet
@en
Olivier Renaudet
@es
Olivier Renaudet
@fr
Olivier Renaudet
@nl
Olivier Renaudet
@sl
P214
P227
P244
P269
P1053
B-6120-2014
P106
P1153
6602195394
P21
P213
0000 0003 5901 2770
P214
P227
1070924695
P244
ns2014000607
P269
P31
P3829
P496
0000-0003-4963-3848
P569
1973-01-01T00:00:00Z
P735
P7859
lccn-ns2014000607